Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Compliance, risk, and the opioid scandal

Tom Fox | July 24, 2017

The opioid epidemic has ravaged many lives in America. Now, the government is turning its focus on the pharmaceutical manufacturers themselves, not the addict or drug abuser.

Several states have filed lawsuits alleging that pharmaceutical companies help fuel the addiction crisis. Oklahoma Attorney General Mike Hunter in June filed a lawsuit against four leading manufacturers of opioid pain medication—Purdue Pharma, Allergan, Cephalon, and Janssen Pharmaceuticals—“claiming the effects of deceptive marketing campaigns over the last decade have fueled the state’s opioid epidemic.” Other states to file lawsuits include Mississippi, Ohio, and Missouri.

In some cases, the government has targed drug companies for failed internal controls. As Compliance Week...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.